Total Parenteral Nutrition-induced Cholestasis

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
1
Soybean oilPhase 31 trial
Active Trials
NCT01565278Terminated2Est. Aug 2015
Hamilton medical
Hamilton medicalSwitzerland - Bonaduz
1 program
1
Soybean oilPhase 3

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fresenius KabiSoybean oil

Clinical Trials (1)

Total enrollment: 2 patients across 1 trials

Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition

Start: Feb 2012Est. completion: Aug 20152 patients
Phase 3Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space